Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim Products

Autor: Mouslim, Morgane C., Trujillo, Antonio J., Alexander, G. Caleb, Segal, Jodi B.
Zdroj: In Value in Health December 2020 23(12):1599-1605
Databáze: ScienceDirect